Stock Options: Why Timing Matters More Than Most Think
Stock options are one of the most valuable components of executive compensation, and also one of the most consistently mismanaged. Not because executives don't understand them in theory, but because the decisions around them tend to get deferred.
That's the first mistake I see. An executive gets granted options, the vesting schedule feels distant, and other priorities take over. Years pass. The options sit unexercised because there's no deadline forcing a decision and no natural trigger to prompt one. By the time the executive actually focuses on them, the expiration dates are close and the exercise has to happen quickly.
That's when the second mistake kicks in.
The Forced Exercise Year
When options have to be exercised in a compressed window, several things happen simultaneously. The exercise itself is a taxable event for non-qualified options, taxed as ordinary income on the spread between the grant price and the fair market value at exercise. Stack that income on top of your salary, bonus, and any RSU vesting in the same year, and you've created a tax bill that your planning was never designed to cover.
For executives with incentive stock options the picture is different but not better. ISOs don't trigger ordinary income at exercise, but they can trigger the Alternative Minimum Tax, which surprises executives who didn't see it coming and creates cash flow problems even when the economic outcome looks good on paper.
Either way, the compressed timeline eliminates most of the planning tools that would have been available if the exercise had been spread across multiple years. Tax bracket management, loss harvesting to offset gains, charitable giving strategies, Roth conversion planning — all of these become much less useful when everything happens at once.
The Concentration Problem That Follows
The other issue with a large single-year exercise is what happens to the resulting position. When you exercise options you own company stock, often a significant amount of it. For an executive whose base salary, bonus, and career trajectory are already tied to the same company, that concentration is a real exposure.
The executives I work with in Morris County and throughout northern New Jersey often have 30, 40, even 50% of their net worth tied up in the stock of a single pharma employer. That's not a diversification problem in the textbook sense. It's a real financial risk. A single adverse clinical trial, a regulatory setback, a leadership change, or a broader sector downturn can take a meaningful portion of your wealth with it. And because your income is tied to the same company, the correlation compounds the damage at exactly the wrong time.
The right exercise strategy considers this from the beginning. When you exercise matters. What you do with the shares afterward matters more.
What Experience Has Taught Me
A few things have become clear after nearly two decades of working with executives on these decisions.
First, the best option strategies start years before the exercise, not months. An executive who maps out their exercise plan across a three to five year window has exponentially more tools available than one who waits until the options are about to expire. This isn't sophisticated planning. It's just early planning.
Second, there is no universally correct time to exercise. The right answer depends on your marginal tax rate this year versus next, your view on the company's stock price, your cash flow needs, and what other income events are happening in parallel. An advisor who gives you a formula without asking those questions isn't actually planning.
Third, this work is done in partnership, not in isolation. For every client with meaningful options exposure, we work in tandem with your CPA to develop a yearly game plan that coordinates the tax and investment sides of the decision. Your CPA knows your return. I know your broader financial picture. Neither of us has the full story without the other. The executives who come out ahead are the ones whose advisors actually talk to each other.
Fourth, the decision of what to do with the shares after exercise is at least as important as the exercise itself. Holding concentrated stock because you believe in the company is understandable. Holding it without a plan to diversify over time is a mistake most executives only recognize in hindsight.
What to Do Right Now
If you have options that are approaching expiration, or if you've been deferring decisions on them, this is the right moment to get specific. Pull your grant documents and confirm the exact vesting and expiration dates. Identify which are ISOs and which are non-qualified. Run a rough projection of what a full exercise would mean for your tax bill in the current year.
If the answer is a number that surprises you, that's the signal to build a multi-year exercise strategy rather than waiting until you have no choice.
This is exactly the kind of work I do with executives in the pharma and life sciences space, typically in coordination with your existing CPA. I hold the CFP®, CIMA®, and CPWA® designations, with the latter two earned through the Yale School of Management. I work with a small number of clients by design, which means when you engage with me, you get my full attention on these decisions.
I'm based in Chester, NJ and serve executives throughout Morris County, Somerset County, and the broader northern New Jersey corridor. If your options picture has gotten complicated enough that you want a second set of eyes on it, reach out directly.
Bill Clinton, CFP®, CIMA®, CPWA® Riverstone Wealth Planners Chester, NJ 908-888-6906 Bill.Clinton@LPL.com
Securities and advisory services offered through LPL Financial, a registered investment advisor, Member FINRA/SIPC.
